Dr. Matthew Ficinski, MD

Dr. Ficinski practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Ficinski's NPI, 1629599261, was assigned on July 5, 2017. Dr. Ficinski holds Wisconsin license 82035.

Dr. Ficinski's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Ficinski's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. Dr. Ficinski is also affiliated with Froedtert Menomonee Falls Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Ficinski to 1 more hospital, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ficinski practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Ficinski's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Ficinski is licensed in Wisconsin.

CMS data shows 204 Medicare services from Dr. Ficinski across 5 procedure codes in 2024, for 98 Medicare patients. Medicare paid $18,631 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 98 Medicare patients who saw Dr. Ficinski in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 3.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ficinski's median patient age at 63, with 49% women.

In 2024, Dr. Ficinski wrote 286 Medicare Part D claims for 57 patients. 93% of them were for generic drugs. CMS names the drug for 183 of them, across 10 drugs with 11 or more claims each, at $18,225 in total drug cost. In 2020, CMS named 36 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Ficinski for performance year 2024, reported as part of a group. Dr. Ficinski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ficinski as offering telehealth.

CMS Open Payments shows 9 general payments to Dr. Ficinski from 6 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $230.